Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Boston Clinical Trials, INC.
mi
from
Boston, MA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Thomas Jefferson University Mood Disorder Program
mi
from
Philadelphia, PA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Thomas Jefferson University Mood Disorder Program
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
BioBehavioral Research of Austin
mi
from
Austin, TX
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
BioBehavioral Research of Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
University of Virginia Center for Psychiatric Research
mi
from
Charlottesville, VA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
University of Virginia Center for Psychiatric Research
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Combined Illness Management and Psychotherapy in Treating Depressed Elders
Combined Illness Management and Psychotherapy in Treating Depressed Elders
Status: Enrolling
Updated:  4/4/2017
Iowa City VA Health Care System
mi
from
Iowa City, IA
Combined Illness Management and Psychotherapy in Treating Depressed Elders
Combined Illness Management and Psychotherapy in Treating Depressed Elders
Status: Enrolling
Updated: 4/4/2017
Iowa City VA Health Care System
mi
from
Iowa City, IA
Click here to add this to my saved trials
Combined Illness Management and Psychotherapy in Treating Depressed Elders
Combined Illness Management and Psychotherapy in Treating Depressed Elders
Status: Enrolling
Updated:  4/4/2017
University of Iowa
mi
from
Iowa City, IA
Combined Illness Management and Psychotherapy in Treating Depressed Elders
Combined Illness Management and Psychotherapy in Treating Depressed Elders
Status: Enrolling
Updated: 4/4/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors
Status: Enrolling
Updated:  4/4/2017
Wexner Medical Center at The Ohio State University Department of Psychiatry
mi
from
Columbus, OH
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors
Status: Enrolling
Updated: 4/4/2017
Wexner Medical Center at The Ohio State University Department of Psychiatry
mi
from
Columbus, OH
Click here to add this to my saved trials
MRI Studies of Emotion in Depression
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response
Status: Enrolling
Updated:  4/5/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
MRI Studies of Emotion in Depression
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response
Status: Enrolling
Updated: 4/5/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
San Diego, CA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Atlanta, GA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Baltimore, MD
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Houston, TX
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Chino, CA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Research Site
mi
from
Lond Beach, CA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Research Site
mi
from
Lond Beach, CA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Stanford, CA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
New Heaven, CT
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
New Heaven, CT
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Gainsville, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Gainsville, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Lake City, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Lake City, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Miami, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Orlando, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
St Petersburg, FL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
St Petersburg, FL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Decatur, GA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Hoffman Estates, IL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Joliet, IL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Joliet, IL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Skokie, IL
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Skokie, IL
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Lake Charles, LA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Lake Charles, LA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Shreveport, LA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Boston, MA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Minneapolis, MN
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
St. Louis, MO
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Willingboro, NJ
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Willingboro, NJ
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Mount Kisco, NY
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
New York, NY
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Rochester, NY
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Cincinnati, OH
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Dayton, OH
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Philadelphia, PA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Dallas, TX
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Bellevue, WA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Research Site
mi
from
Antofagasta,
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Research Site
mi
from
Antofagasta,
Click here to add this to my saved trials
The Implantable Cardioverter-defibrillators (ICD)/Device Expectations, Adaptations, and Successes Study
The ICD/Device Expectations, Adaptations, and Successes (IDEAS) Study: the Relationship Between Implantable Cardioverter-defibrillators, Pacemakers and Psychiatric Symptoms in a Pediatric Population
Status: Enrolling
Updated:  4/12/2017
Children's Hospital Boston
mi
from
Boston, MA
The Implantable Cardioverter-defibrillators (ICD)/Device Expectations, Adaptations, and Successes Study
The ICD/Device Expectations, Adaptations, and Successes (IDEAS) Study: the Relationship Between Implantable Cardioverter-defibrillators, Pacemakers and Psychiatric Symptoms in a Pediatric Population
Status: Enrolling
Updated: 4/12/2017
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Natural Supplements for Unipolar Depression
Phase 4 Study: An Open Study of the Efficacy and Tolerability in Unipolar Depression of Augmentation of the One-carbon Cycle With L-methionine, Betaine and Folate
Status: Enrolling
Updated:  4/17/2017
Cambridge Health Alliance
mi
from
Cambridge, MA
Natural Supplements for Unipolar Depression
Phase 4 Study: An Open Study of the Efficacy and Tolerability in Unipolar Depression of Augmentation of the One-carbon Cycle With L-methionine, Betaine and Folate
Status: Enrolling
Updated: 4/17/2017
Cambridge Health Alliance
mi
from
Cambridge, MA
Click here to add this to my saved trials
Ropinirole in the Treatment of Bipolar Depression
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder
Status: Enrolling
Updated:  4/17/2017
Cambridge Health Alliance
mi
from
Cambridge, MA
Ropinirole in the Treatment of Bipolar Depression
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder
Status: Enrolling
Updated: 4/17/2017
Cambridge Health Alliance
mi
from
Cambridge, MA
Click here to add this to my saved trials
Ropinirole in the Treatment of Bipolar Depression
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder
Status: Enrolling
Updated:  4/17/2017
Emory University
mi
from
Atlanta, GA
Ropinirole in the Treatment of Bipolar Depression
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder
Status: Enrolling
Updated: 4/17/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/17/2017
NWMS Bonney Lake — Medical Oncology
mi
from
Bonney Lake, WA
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
NWMS Bonney Lake — Medical Oncology
mi
from
Bonney Lake, WA
Click here to add this to my saved trials
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/17/2017
NWMS Federal Way — Medical Oncology
mi
from
Federal Way, WA
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
NWMS Federal Way — Medical Oncology
mi
from
Federal Way, WA
Click here to add this to my saved trials
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/17/2017
NWMS Gig Harbor — Medical Oncology
mi
from
Gig Harbor, WA
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
NWMS Gig Harbor — Medical Oncology
mi
from
Gig Harbor, WA
Click here to add this to my saved trials
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/17/2017
NWMS Lakewood — Medical Oncology
mi
from
Lakewood, WA
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
NWMS Lakewood — Medical Oncology
mi
from
Lakewood, WA
Click here to add this to my saved trials